{
    "clinical_study": {
        "@rank": "102386", 
        "arm_group": {
            "arm_group_label": "Cohort"
        }, 
        "brief_summary": {
            "textblock": "This non-interventional study will compare the Cobas BRAF V600 mutation assay with in-house\n      methods used in molecular laboratories for the assessment of the BRAF mutation status in\n      melanoma tumor samples. No patients will be enrolled in this study. Data will be collected\n      for approximately 6 months."
        }, 
        "brief_title": "Comparison of In-House Methods and Cobas BRAF V600 Mutation Assay in Melanoma Tumor Samples", 
        "completion_date": {
            "#text": "April 2013", 
            "@type": "Actual"
        }, 
        "condition": "Malignant Melanoma", 
        "condition_browse": {
            "mesh_term": "Melanoma"
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n        No patients are enrolled. Use of tumor samples only.\n\n          -  Histologically proven melanoma tumor sample\n\n          -  Any type of tumor sample: biopsy or surgical specimen of primary tumor or metastasis\n\n          -  Tumor samples must be fixed and paraffin-embedded.\n\n        Exclusion Criteria:\n\n        No patients are enrolled. Use of tumor samples only.\n\n          -  Fixative unknown"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "N/A", 
            "sampling_method": "Probability Sample", 
            "study_pop": {
                "textblock": "No patients are enrolled in this study. Use of melanoma tumor samples."
            }
        }, 
        "enrollment": {
            "#text": "420", 
            "@type": "Actual"
        }, 
        "firstreceived_date": "December 6, 2012", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01744860", 
            "org_study_id": "ML28471"
        }, 
        "is_fda_regulated": "No", 
        "lastchanged_date": "May 5, 2014", 
        "location": [
            {
                "facility": {
                    "address": {
                        "city": "Boulogne Billancourt", 
                        "country": "France", 
                        "zip": "92104"
                    }
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Colmar", 
                        "country": "France", 
                        "zip": "68024"
                    }
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Lille", 
                        "country": "France", 
                        "zip": "59037"
                    }
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Lyon", 
                        "country": "France", 
                        "zip": "69437"
                    }
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Marseille", 
                        "country": "France", 
                        "zip": "13015"
                    }
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Montpellier", 
                        "country": "France", 
                        "zip": "34295"
                    }
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Nantes", 
                        "country": "France", 
                        "zip": "44093"
                    }
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Paris", 
                        "country": "France", 
                        "zip": "75010"
                    }
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Pessac", 
                        "country": "France", 
                        "zip": "33604"
                    }
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Rouen", 
                        "country": "France", 
                        "zip": "76031"
                    }
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Vandoeuvre Les Nancy", 
                        "country": "France", 
                        "zip": "54511"
                    }
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Villejuif", 
                        "country": "France", 
                        "zip": "94505"
                    }
                }
            }
        ], 
        "location_countries": {
            "country": "France"
        }, 
        "number_of_groups": "1", 
        "official_title": "Evaluation of Concordance Between the Cobas\u00ae BRAF V600 Mutation Assay and the Methods Used in INCa Platforms for Detection of BRAF V600 Mutations in Melanoma in Real Life Setting", 
        "overall_official": {
            "affiliation": "Hoffmann-La Roche", 
            "last_name": "Clinical Trials", 
            "role": "Study Director"
        }, 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "France: Ministry of Health"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "April 2013", 
            "@type": "Actual"
        }, 
        "primary_outcome": {
            "measure": "BRAF mutation status of melanoma tumor samples according to cobas\u00ae 4800 BRAF V600 Mutation Test vs. INCa laboratories molecular genetics platform", 
            "safety_issue": "No", 
            "time_frame": "Approximately 6 months"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01744860"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": [
            {
                "measure": "Type of tumor sample", 
                "safety_issue": "No", 
                "time_frame": "Approximately 6 months"
            }, 
            {
                "measure": "Type of pre-analytical method used in the preparation of the tumor sample for BRAF V600 mutation detection", 
                "safety_issue": "No", 
                "time_frame": "Approximately 6 months"
            }, 
            {
                "measure": "Final result for BRAF V600 mutation detection", 
                "safety_issue": "No", 
                "time_frame": "Approximately 6 months"
            }
        ], 
        "source": "Hoffmann-La Roche", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Hoffmann-La Roche", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "December 2012", 
        "study_design": "Observational Model: Cohort, Time Perspective: Prospective", 
        "study_type": "Observational", 
        "verification_date": "May 2014"
    }
}